YPrime Unveils a Transformative Brand Focused on Solving for Certainty in Clinical Trials

Clinical trial technology leader amplifies its dedication to empowering researchers and revolutionizing the clinical trial landscape

MALVERN, Pa., Jan. 22, 2024 (GLOBE NEWSWIRE) -- YPrime, the leading pioneer in clinical trial technology, today announced a bold brand evolution initiative that articulates its commitment to provide cutting-edge solutions focused on delivering streamlined and accelerated clinical trials, increasing certainty from study design to data lock. This strategic update includes a vibrant visual identity, a new logo, and a clear company mission/vision, underscoring a nearly two-decade legacy of innovation and partnership in the clinical trial space.

"Innovation and quality have been the hallmarks of YPrime's journey, leading to significant advancements in clinical research. As we transition to our next growth phase, our new brand identity is a beacon of our unwavering dedication to transformative clinical trial experiences," said Jim Corrigan, Chief Executive Officer at YPrime. "We are inspired to make life better for patients and clinicians and help pharmaceutical and biopharmaceutical companies of all sizes solve for certainty." 

YPrime Brand Launch Image

Clinical trials are integral to unlocking life-saving treatments that impact patients, their families, and caretakers. Yet, the industry continues to experience poor operational performance, causing timeline delays, data quality concerns, and underachieving patient recruitment/retention targets. YPrime's new tagline, Solving for Certainty, reaffirms its focus on collaborating with sponsors and Contract Research Organizations (CROs) to improve the operational performance of clinical trials.

"Today marks a pivotal moment as we elevate our commitment to overcoming industry hurdles with agile and patient-centric technology," continues Corrigan. "Our technology suite, including eConsent, eCOA, IRT, and patient engagement solutions, is specifically designed to meet many of the evolving needs of the life sciences sector."

YPrime's technology platform enables speed, flexibility, and certainty for large and emerging pharma companies. YPrime invites all stakeholders to explore the reimagined brand and engage with the solutions set that transforms clinical research at www.yprime.com. 

About YPrime
At YPrime, we pioneer solutions that streamline the clinical trial journey, increasing certainty from study design to data lock. With a foundation built on decades of industry insight and expertise, we are inspired by the life-altering outcomes unlocked by clinical trials. Our dedication to quality is pivotal in propelling the groundbreaking endeavors of our partners, researchers, and investigators. With a technology platform that enables speed, flexibility, and certainty for large and emerging pharma companies alike, we provide eConsent, IRT, eCOA, and patient engagement solutions that solve for certainty in clinical research. To learn more, email marketing@yprime.com or visit www.yprime.com.

Media Contact
Terry Rehm

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/2ad9ab0f-7229-40c0-9d17-246fce75619a